<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FT922-9570</title>
	</head>
	<body>
		<main>
			<p>920507 FT  07 MAY 92 / International Company News: Hafslund Nycomed advances 46% HAFSLUND Nycomed, the Norwegian company which makes radiology products to improve the clarity of X-rays, yesterday announced a 46 per cent rise in pre-tax profits to NKr367m (Dollars 57.29m) for the first quarter of 1992. Operating profit, after research and development costs, improved by NKr66m to NKr410m. R&amp;D costs rose by NKr27m to NKr168m. Sales rose 10 per cent to NKr1.415bn. Hafslund made a NKr43m loss on securities, bonds and foreign currency trading during the three months, against a NKr111m loss last year. Hafslund reiterated plans to spin-off its shipping operations into a separate company, Actinor Shipping. The group plans to retain a 25 per cent stake and around the middle of the year take a listing for Actinor on the New York Stock Exchange. Among individual business units, Nycomed Imaging made satisfactory progress in all markets in the quarter although operating revenue was up NKr4m to NKr567m. Nycomed Pharma saw steady growth in pharmaceutical sales and improved operating revenue by NKr78m to NKr613m with operating profit NKr25m higher at NKr123m.</p>
		</main>
</body></html>
            